In pre-clinical studies of head and neck squamous cell carcinoma cells that express HIF1α, it was found that in the setting of hypoxia, where HIF1α expression is increased, the cytotoxicity of SN38, the active metabolite of irinotecan, was enhanced with the addition of MSA [41]. The gene discussed is HIF1A; the disease is head and neck squamous cell carcinoma.